Woebot Health
AI mental health at scale
San Francisco, CA, US
Woebot Health, founded in 2014 and headquartered in San Francisco, California, develops digital therapeutics and mental wellness applications using conversational AI chatbots. It specializes in cognitive behavioral therapy (CBT), interpersonal psychotherapy (IPT), and dialectical behavior therapy (DBT). The company pivoted its business model in mid-2025 from direct-to-consumer to enterprise-focused.
How We Help
Problem Statement
Woebot Health develops digital therapeutics and mental wellness applications using conversational AI chatbots to provide mental health support based on cognitive behavioral therapy (CBT), interpersonal psychotherapy (IPT), and dialectical behavior therapy (DBT).
Core Technology
conversational AI chatbots
Key Differentiators
FDA Breakthrough Device Designation for its postpartum depression digital therapeutic (WB001); Specializes in cognitive behavioral therapy (CBT), interpersonal psychotherapy (IPT), and dialectical behavior therapy (DBT) delivered via smartphone-based chatbot interfaces; Pivoted to an enterprise-focused B2B model, targeting payers, providers, and employers; Offers an enterprise platform including Woebot for Adults, Woebot for Adolescents, and Woebot for Maternal Health; ISO:13485-certified quality management system and HIPAA compliant
Clinical Focus
mental health; cognitive behavioral therapy; interpersonal psychotherapy; dialectical behavior therapy
Company Info
- Business Model
- B2B SaaS
- Founded
- 2014
- Total Funding
- 114,000,000
- Website
- woebothealth.com/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA Breakthrough Device Designation (WB001 for postpartum depression). Pivotal RCT ongoing for postpartum depression. Published RCTs in JMIR and PMC: 44% depression symptom reduction in young adults; 70% postpartum depression users achieved clinical improvement. HIPAA compliant; ORCHA certified.
MedStartr Index Score
?What do you think of Woebot Health?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.